HPV vaccine prevents cancer, but new ACIP working group will re-examine evidence.
An op‑ed reports that HPV vaccination has led to large reductions in cervical cancer and precancer in multiple countries, and that a newly formed ACIP working group plans a multi‑year comprehensive review of the vaccine’s efficacy, safety, and dosing, including questions about single‑dose protection and adjuvant concerns.
